Regulatory concerns shouldn't deter pharma brands from social media: Weber Shandwick

GLOBAL - Internal barriers rather than regulatory concerns are hindering pharmaceutical companies’ ability to build their brands across social media, according to a study conducted by Weber Shandwick and Forbes Insights.

by Byravee Iyer